1. Home
  2. VREX vs AGMB Comparison

VREX vs AGMB Comparison

Compare VREX & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$11.97

Market Cap

580.6M

Sector

Technology

ML Signal

HOLD

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$11.53

Market Cap

677.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VREX
AGMB
Founded
2016
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
580.6M
677.9M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
VREX
AGMB
Price
$11.97
$11.53
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$16.67
$32.00
AVG Volume (30 Days)
202.1K
190.1K
Earning Date
05-07-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
N/A
Revenue Next Year
$3.88
$33.33
P/E Ratio
$232.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$9.00
52 Week High
$14.57
$17.45

Technical Indicators

Market Signals
Indicator
VREX
AGMB
Relative Strength Index (RSI) 61.43 49.08
Support Level $11.43 $9.71
Resistance Level $12.61 $12.06
Average True Range (ATR) 0.35 1.26
MACD 0.22 0.21
Stochastic Oscillator 89.06 86.27

Price Performance

Historical Comparison
VREX
AGMB

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: